Portfolio transformation between Pharma Giants - GlaxoSmithKline, Novartis & Lilly
(24th Apr, 2014); Now Novartis will focus more on oncology business, GlaxoSmithKline will focus on vaccines business and Lilly to concentrate more on Animal Health Division, concluded from portfolio transformation deals between said companies.